{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:09:40Z","timestamp":1793394580922,"version":"4.5.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) therapies lead to variable remission and response rates in patients participating in clinical trials, likely due to interindividual target variability, differences in active biological pathways, feedback, and\/or resistance mechanisms. Here, we stratified patients into subtypes by characterizing heterogeneity using mucosal biopsy transcriptomics data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Transcriptomics data from an andecaliximab phase 2\/3 study in patients with UC were scored for gene signature enrichment. Eleven Reactome gene sets, moderately correlated with histological disease activity using Robarts Histopathology Index with low correlation to each other, were selected and evaluated in baseline gene expression data of ustekinumab, infliximab, and adalimumab clinical trials in patients with UC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 11 gene sets, referred to as \u201cMetabolism and Response to Stress\u201d (MARS) signatures, 5 correlated with \u201cnon-disease\u201d mucosa and 6 with \u201cdisease-related\u201d mucosa. Clustering baseline andecaliximab samples scored with MARS revealed 3 clusters with low non-disease\/high disease-related, high non-disease\/low disease-related, or a mixture. Importantly, these clusters did not correlate with patient demographics, clinical characteristics, or disease activity metrics. Clustering baseline data from other clinical trials (anti-interleukin-12\/23 and anti-tumor necrosis factor) in patients with UC scored with MARS showed that patients in low non-disease\/high disease-related baseline score clusters less likely to achieve treatment response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We identified and evaluated a novel, multi-dimensional signature gene set to characterize previously undefined heterogeneity in patients with UC and identify patients less likely to respond to therapy. This approach offers potential utility to define clinical trial populations, enrich for clinical responders, and identify difficult-to-treat populations for therapeutic development.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjaf092","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T13:31:46Z","timestamp":1749475906000},"source":"Crossref","is-referenced-by-count":5,"title":["Metabolism and response to stress gene signatures reveal ulcerative colitis heterogeneity and identify patients with increased response to therapy"],"prefix":"10.1093","volume":"19","author":[{"given":"Bryan","family":"Linggi","sequence":"first","affiliation":[{"name":"Alimentiv Inc. , London, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Filice","sequence":"additional","affiliation":[{"name":"Alimentiv Inc. , London, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sangiorgi","sequence":"additional","affiliation":[{"name":"Alimentiv Inc. , London, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle I","family":"Smith","sequence":"additional","affiliation":[{"name":"Alimentiv Inc. , London, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Teft","sequence":"additional","affiliation":[{"name":"Alimentiv Inc. , London, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-0033","authenticated-orcid":false,"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[{"name":"Alimentiv Inc. , London, ON ,","place":["Canada"]},{"name":"Division of Gastroenterology, Department of Medicine, Western University , London, ON ,","place":["Canada"]},{"name":"Department of Epidemiology and Biostatistics, Western University , London, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-9948","authenticated-orcid":false,"given":"Christopher","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Cumming School of Medicine, University of Calgary , Calgary, AB ,","place":["Canada"]},{"name":"Department of Community Health Sciences, Cumming School of Medicine, University of Calgary , Calgary, AB ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-0274","authenticated-orcid":false,"given":"Niels","family":"Vande Casteele","sequence":"additional","affiliation":[{"name":"AcelaBio, Inc. , San Diego, CA ,","place":["United States"]},{"name":"Department of Medicine, University of California San Diego , La Jolla, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"2025063009414333200_CIT0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12950-020-00246-4","article-title":"Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies","volume":"17","author":"Kaur","year":"2020","journal-title":"J Inflamm (Lond)."},{"key":"2025063009414333200_CIT0002","doi-asserted-by":"crossref","first-page":"643973","DOI":"10.3389\/fmed.2021.643973","article-title":"Intestinal mucosal wound healing and barrier integrity in IBD-crosstalk and trafficking of cellular players","volume":"8","author":"Sommer","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"2025063009414333200_CIT0003","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet."},{"key":"2025063009414333200_CIT0004","doi-asserted-by":"crossref","first-page":"otad009","DOI":"10.1093\/crocol\/otad009","article-title":"Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis at induction and maintenance: an indirect treatment comparison using Bayesian network meta-analysis","volume":"5","author":"Panaccione","year":"2023","journal-title":"Crohns Colitis 360."},{"key":"2025063009414333200_CIT0005","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology."},{"key":"2025063009414333200_CIT0006","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","article-title":"Il-12 and il-23 pathway inhibition in inflammatory bowel disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2025063009414333200_CIT0007","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41575-021-00574-7","article-title":"Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease","volume":"19","author":"Verstockt","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2025063009414333200_CIT0008","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1038\/ctg.2015.63","article-title":"Loss of response to anti-TNFs: definition, epidemiology, and management","volume":"7","author":"Roda","year":"2016","journal-title":"Clin Transl Gastroenterol."},{"key":"2025063009414333200_CIT0009","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1038\/s41598-021-88489-w","article-title":"Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy","volume":"11","author":"Penrose","year":"2021","journal-title":"Sci Rep."},{"key":"2025063009414333200_CIT0010","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/gutjnl-2021-326451","article-title":"Biopsy and blood-based molecular biomarker of inflammation in IBD","volume":"72","author":"Argmann","year":"2023","journal-title":"Gut."},{"key":"2025063009414333200_CIT0011","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell."},{"key":"2025063009414333200_CIT0012","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ibd.23020","article-title":"Evaluation of responsive gene expression as a sensitive and specific biomarker in patients with ulcerative colitis","volume":"19","author":"Roman","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2025063009414333200_CIT0013","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/apt.15126","article-title":"Mucosal il13ra2 expression predicts nonresponse to anti-TNF therapy in Crohn\u2019s disease","volume":"49","author":"Verstockt","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"2025063009414333200_CIT0014","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin m drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat Med."},{"key":"2025063009414333200_CIT0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41467-018-07841-3","article-title":"Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response","volume":"10","author":"Haberman","year":"2019","journal-title":"Nat Commun."},{"key":"2025063009414333200_CIT0016","doi-asserted-by":"crossref","first-page":"18243","DOI":"10.1038\/s41598-021-97366-5","article-title":"Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis","volume":"11","author":"Linggi","year":"2021","journal-title":"Sci Rep."},{"key":"2025063009414333200_CIT0017","doi-asserted-by":"crossref","first-page":"e8061","DOI":"10.7717\/peerj.8061","article-title":"Identification of genes and functional coexpression modules closely related to ulcerative colitis by gene datasets analysis","volume":"7","author":"Zhu","year":"2019","journal-title":"PeerJ."},{"key":"2025063009414333200_CIT0018","first-page":"1021","article-title":"Andecaliximab [anti-matrix metalloproteinase-9] induction therapy for ulcerative colitis: a randomised, double-blind, placebo-controlled, phase 2\/3 study in patients with moderate to severe disease","volume":"12","author":"Sandborn","year":"2018","journal-title":"J Crohns Colitis."},{"key":"2025063009414333200_CIT0019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut."},{"key":"2025063009414333200_CIT0020","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1038\/s41467-022-33331-8","article-title":"Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy","volume":"13","author":"Pavlidis","year":"2022","journal-title":"Nat Commun."},{"key":"2025063009414333200_CIT0021","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/gut.2009.178665","article-title":"Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis","volume":"58","author":"Arijs","year":"2009","journal-title":"Gut."},{"key":"2025063009414333200_CIT0022","doi-asserted-by":"crossref","first-page":"e1006951","DOI":"10.1371\/journal.pcbi.1006951","article-title":"I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment","volume":"15","author":"Pavlidis","year":"2019","journal-title":"PLoS Comput Biol."},{"key":"2025063009414333200_CIT0023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2016-312293","article-title":"Effect of vedolizumab (anti-alpha4beta7-integrin) therapy on histological healing and mucosal gene expression in patients with UC","volume":"67","author":"Arijs","year":"2018","journal-title":"Gut."},{"key":"2025063009414333200_CIT0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2013.05.048","article-title":"Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology."},{"key":"2025063009414333200_CIT0025","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"Geoquery: a bridge between the gene expression omnibus (geo) and bioconductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics."},{"key":"2025063009414333200_CIT0026","article-title":"National Center for Biotechnology Information","author":"National Library of Medicine","year":"2024","journal-title":"Geo. Gene expression omnibus"},{"key":"2025063009414333200_CIT0027","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI geo: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2025063009414333200_CIT0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"2025063009414333200_CIT0029","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1158\/0008-5472.CAN-17-0344","article-title":"Software for the integration of multiomics experiments in bioconductor","volume":"77","author":"Ramos","year":"2017","journal-title":"Cancer Res."},{"key":"2025063009414333200_CIT0030","article-title":"Practices of medical and health data analysis using r","author":"Nakazawa","year":"2023"},{"key":"2025063009414333200_CIT0031","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/978-1-4419-9863-7_1215","article-title":"Benjamin-Hochberg method","volume-title":"Encyclopedia of Systems Biology.","author":"Haynes","year":"2013"},{"key":"2025063009414333200_CIT0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"2025063009414333200_CIT0033","article-title":"GSEABase: gene set enrichment data structures and methods","author":"Morgan","year":"2020"},{"key":"2025063009414333200_CIT0034","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2025063009414333200_CIT0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigGDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"2025063009414333200_CIT0036","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics."},{"key":"2025063009414333200_CIT0037","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/15366367.2019.1565254","article-title":"Ggplot2: elegant graphics for data analysis (2nd ed.)","volume":"17","author":"Villanueva","year":"2019","journal-title":"Meas Interdiscip Res Perspect."},{"key":"2025063009414333200_CIT0038","article-title":"Functions for medical statistics book with some demographic data","author":"Nakazawa"},{"key":"2025063009414333200_CIT0039","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"iMeta."},{"key":"2025063009414333200_CIT0040","article-title":"\u201cfinding groups in data\u201d: cluster analysis extended Rousseeuw et al","author":"Maechler","year":"2016"},{"key":"2025063009414333200_CIT0041","author":"The Reactome project","year":"2024"},{"key":"2025063009414333200_CIT0042","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2018.06.077","article-title":"Gene expression signature for prediction of golimumab response in a phase 2a open-label trial of patients with ulcerative colitis","volume":"155","author":"Telesco","year":"2018","journal-title":"Gastroenterology."},{"key":"2025063009414333200_CIT0043","doi-asserted-by":"crossref","first-page":"e00578","DOI":"10.14309\/ctg.0000000000000578","article-title":"Mirikizumab regulates genes involved in ulcerative colitis disease activity and anti-TNF resistance: results from a phase 2 study","volume":"14","author":"Steere","year":"2023","journal-title":"Clin Transl Gastroenterol."},{"key":"2025063009414333200_CIT0044","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1038\/s41467-019-10769-x","article-title":"Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification","volume":"10","author":"Czarnewski","year":"2019","journal-title":"Nat Commun."},{"key":"2025063009414333200_CIT0045","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/ecco-jcc\/jjab085","article-title":"Immunological networks defining the heterogeneity of inflammatory bowel diseases","volume":"15","author":"Selin","year":"2021","journal-title":"J Crohns Colitis."},{"key":"2025063009414333200_CIT0046","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/metabo9120291","article-title":"Mucosal metabolomic profiling and pathway analysis reveal the metabolic signature of ulcerative colitis","volume":"9","author":"Diab","year":"2019","journal-title":"Metabolites."},{"key":"2025063009414333200_CIT0047","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/ibd\/izad060","article-title":"Novel mRNA signature for anti-TNF-alpha therapy primary response in patients with ulcerative colitis","volume":"29","author":"Yang","year":"2023","journal-title":"Inflamm Bowel Dis."},{"key":"2025063009414333200_CIT0048","doi-asserted-by":"crossref","first-page":"1158648","DOI":"10.3389\/fimmu.2023.1158648","article-title":"Comprehensive analysis of endoplasmic reticulum stress-associated genes signature of ulcerative colitis","volume":"14","author":"Deng","year":"2023","journal-title":"Front Immunol."},{"key":"2025063009414333200_CIT0049","doi-asserted-by":"crossref","first-page":"697360","DOI":"10.3389\/fphar.2021.697360","article-title":"Regulation of endoplasmic reticulum stress-autophagy: a potential therapeutic target for ulcerative colitis","volume":"12","author":"Qiao","year":"2021","journal-title":"Front Pharmacol."},{"key":"2025063009414333200_CIT0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.34.2.247","article-title":"Thromboembolism in inflammatory bowel disease: role of platelets","volume":"34","author":"Webberley","year":"1993","journal-title":"Gut."},{"key":"2025063009414333200_CIT0051","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/medicina59091615","article-title":"Treatment of ulcerative colitis: impact on platelet aggregation","volume":"59","author":"Peric","year":"2023","journal-title":"Medicina (Kaunas, Lithuania)."},{"key":"2025063009414333200_CIT0052","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fcimb.2018.00395","article-title":"Targeting Il-13 as a host-directed therapy against ulcerative colitis","volume":"8","author":"Hoving","year":"2018","journal-title":"Front Cell Infect Microbiol."},{"key":"2025063009414333200_CIT0053","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/gutjnl-2012-303461","article-title":"Interleukin 13 and its role in gut defence and inflammation","volume":"61","author":"Mannon","year":"2012","journal-title":"Gut."},{"key":"2025063009414333200_CIT0054","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/gutjnl-2014-308337","article-title":"Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study","volume":"64","author":"Reinisch","year":"2015","journal-title":"Gut."},{"key":"2025063009414333200_CIT0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gutjnl-2014-308004","article-title":"Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIA study","volume":"64","author":"Danese","year":"2015","journal-title":"Gut."},{"key":"2025063009414333200_CIT0056","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"Il-13 signaling through the Il-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat Med."},{"key":"2025063009414333200_CIT0057","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.3390\/ijms24065820","article-title":"Differences in whole-blood transcriptional profiles in inflammatory bowel disease patients responding to vedolizumab compared with non-responders","volume":"24","author":"Haglund","year":"2023","journal-title":"Int J Mol Sci ."},{"key":"2025063009414333200_CIT0058","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.3390\/ijms23136944","article-title":"Inverse and concordant mucosal pathway gene expressions in inflamed and non-inflamed ulcerative colitis patients: potential relevance to aetiology and pathogenesis","volume":"23","author":"S\u00f6derman","year":"2022","journal-title":"Int J Mol Sci."},{"key":"2025063009414333200_CIT0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562848241251600","article-title":"Biomarkers in inflammatory bowel disease: a practical guide","volume":"17","author":"Clough","year":"2024","journal-title":"Therap Adv Gastroenterol."}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjaf092\/63456066\/jjaf092.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/6\/jjaf092\/63456066\/jjaf092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/19\/6\/jjaf092\/63456066\/jjaf092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:41:57Z","timestamp":1751290917000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/doi\/10.1093\/ecco-jcc\/jjaf092\/8158685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf092","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,6]]},"article-number":"jjaf092"}}